Integrated Quantitative Investments LLC acquired a new position in Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 64,125 shares of the company’s stock, valued at approximately $1,098,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank acquired a new stake in shares of Tactile Systems Technology in the 4th quarter worth about $2,534,000. Janney Montgomery Scott LLC bought a new position in shares of Tactile Systems Technology in the fourth quarter worth $1,328,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of Tactile Systems Technology by 163.1% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 52,227 shares of the company’s stock valued at $895,000 after purchasing an additional 32,378 shares during the period. Semanteon Capital Management LP acquired a new stake in Tactile Systems Technology in the fourth quarter worth about $493,000. Finally, Barclays PLC grew its position in Tactile Systems Technology by 56.7% in the 3rd quarter. Barclays PLC now owns 66,885 shares of the company’s stock valued at $977,000 after buying an additional 24,188 shares in the last quarter. 83.43% of the stock is owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, VP Kristie Burns sold 4,830 shares of Tactile Systems Technology stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $14.65, for a total transaction of $70,759.50. Following the completion of the sale, the vice president now owns 84,008 shares in the company, valued at $1,230,717.20. The trade was a 5.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Elaine M. Birkemeyer sold 3,778 shares of Tactile Systems Technology stock in a transaction on Monday, February 24th. The stock was sold at an average price of $14.70, for a total transaction of $55,536.60. Following the sale, the chief financial officer now directly owns 104,098 shares of the company’s stock, valued at $1,530,240.60. This represents a 3.50 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 19,546 shares of company stock worth $285,444 over the last three months. 0.96% of the stock is currently owned by corporate insiders.
Tactile Systems Technology Price Performance
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last issued its earnings results on Tuesday, February 18th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.31 by $0.09. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%. The firm had revenue of $85.59 million during the quarter, compared to analysts’ expectations of $85.39 million. Analysts expect that Tactile Systems Technology, Inc. will post 0.7 EPS for the current year.
Analyst Ratings Changes
Several research analysts recently weighed in on the company. StockNews.com cut Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 29th. B. Riley lowered shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $23.00 to $18.00 in a research report on Wednesday, February 19th.
Read Our Latest Stock Analysis on Tactile Systems Technology
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
See Also
- Five stocks we like better than Tactile Systems Technology
- How to Evaluate a Stock Before BuyingÂ
- Charles Schwab Stock: Trading Up in a Down Market
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
Want to see what other hedge funds are holding TCMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tactile Systems Technology, Inc. (NASDAQ:TCMD – Free Report).
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.